vs
Side-by-side financial comparison of Sphere 3D Corp. (ANY) and Opus Genetics, Inc. (IRD). Click either name above to swap in a different company.
Opus Genetics, Inc. is the larger business by last-quarter revenue ($3.9M vs $2.7M, roughly 1.4× Sphere 3D Corp.). On growth, Sphere 3D Corp. posted the faster year-over-year revenue change (3.1% vs -10.2%). Over the past eight quarters, Opus Genetics, Inc.'s revenue compounded faster (50.3% CAGR vs -37.4%).
Sphere 3D Corp is a global technology company specializing in cloud computing, data management, and virtualization solutions. It delivers enterprise-grade products and services tailored for small to medium-sized businesses, large enterprise clients, and public sector entities, focusing on optimizing IT infrastructure efficiency and cutting operational costs for end users.
Opus Genetics, Inc. is a clinical-stage biotechnology company specializing in the development of targeted gene therapies for inherited retinal diseases. It focuses on addressing unmet medical needs for patients living with rare, vision-threatening ocular conditions, with operations centered on advancing accessible therapeutic candidates for global rare disease patient populations.
ANY vs IRD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $2.7M | $3.9M |
| Net Profit | — | — |
| Gross Margin | — | — |
| Operating Margin | -372.7% | — |
| Net Margin | — | — |
| Revenue YoY | 3.1% | -10.2% |
| Net Profit YoY | — | 53.0% |
| EPS (diluted) | $-6.96 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $2.7M | $3.9M | ||
| Q3 25 | $2.6M | $3.1M | ||
| Q2 25 | $3.0M | $2.9M | ||
| Q1 25 | $2.8M | $4.4M | ||
| Q4 24 | $2.6M | $4.3M | ||
| Q3 24 | $2.4M | $3.9M | ||
| Q2 24 | $4.7M | $1.1M | ||
| Q1 24 | $6.9M | $1.7M |
| Q4 25 | — | — | ||
| Q3 25 | $-4.2M | $-17.5M | ||
| Q2 25 | $1.7M | $-7.4M | ||
| Q1 25 | $-8.8M | $-8.2M | ||
| Q4 24 | — | — | ||
| Q3 24 | $104.0K | $-7.5M | ||
| Q2 24 | $2.1M | $-7.8M | ||
| Q1 24 | $-4.5M | $-7.1M |
| Q4 25 | — | — | ||
| Q3 25 | 25.4% | — | ||
| Q2 25 | 23.8% | — | ||
| Q1 25 | 22.1% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -16.0% | — | ||
| Q2 24 | 15.2% | — | ||
| Q1 24 | 38.0% | — |
| Q4 25 | -372.7% | — | ||
| Q3 25 | -153.8% | -269.9% | ||
| Q2 25 | -87.0% | -309.0% | ||
| Q1 25 | -184.2% | -227.2% | ||
| Q4 24 | -328.7% | — | ||
| Q3 24 | -218.8% | -207.1% | ||
| Q2 24 | -122.4% | -748.9% | ||
| Q1 24 | -26.9% | -450.5% |
| Q4 25 | — | — | ||
| Q3 25 | -162.0% | -566.9% | ||
| Q2 25 | 55.2% | -257.5% | ||
| Q1 25 | -311.9% | -187.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | 4.4% | -194.6% | ||
| Q2 24 | 45.5% | -698.3% | ||
| Q1 24 | -64.5% | -415.3% |
| Q4 25 | $-6.96 | — | ||
| Q3 25 | $-0.15 | $-0.25 | ||
| Q2 25 | $0.06 | $-0.12 | ||
| Q1 25 | $-0.32 | $-0.24 | ||
| Q4 24 | $-4.62 | — | ||
| Q3 24 | $0.01 | $-0.29 | ||
| Q2 24 | $0.10 | $-0.30 | ||
| Q1 24 | $-0.27 | $-0.29 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.7M | $45.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $23.3M | $15.3M |
| Total Assets | $25.1M | $50.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.7M | $45.1M | ||
| Q3 25 | $5.3M | $30.8M | ||
| Q2 25 | $4.7M | $32.4M | ||
| Q1 25 | $2.8M | $41.8M | ||
| Q4 24 | $5.4M | $30.3M | ||
| Q3 24 | $5.0M | $36.6M | ||
| Q2 24 | $4.3M | $41.4M | ||
| Q1 24 | $9.3M | $47.2M |
| Q4 25 | $23.3M | $15.3M | ||
| Q3 25 | $29.5M | $6.0M | ||
| Q2 25 | $32.7M | $17.5M | ||
| Q1 25 | $30.7M | $5.1M | ||
| Q4 24 | $39.3M | $6.7M | ||
| Q3 24 | $35.8M | $34.3M | ||
| Q2 24 | $33.4M | $40.6M | ||
| Q1 24 | $27.5M | $46.1M |
| Q4 25 | $25.1M | $50.2M | ||
| Q3 25 | $31.1M | $36.1M | ||
| Q2 25 | $34.4M | $38.7M | ||
| Q1 25 | $34.3M | $48.2M | ||
| Q4 24 | $43.2M | $36.9M | ||
| Q3 24 | $44.3M | $40.4M | ||
| Q2 24 | $44.0M | $44.8M | ||
| Q1 24 | $42.0M | $51.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-16.1M | $-35.3M |
| Free Cash FlowOCF − Capex | $-23.6M | — |
| FCF MarginFCF / Revenue | -867.3% | — |
| Capex IntensityCapex / Revenue | 275.4% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-40.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-16.1M | $-35.3M | ||
| Q3 25 | $-3.5M | $-6.2M | ||
| Q2 25 | $-5.8M | $-10.3M | ||
| Q1 25 | $-4.1M | $-9.0M | ||
| Q4 24 | $-4.6M | $-25.6M | ||
| Q3 24 | $290.0K | $-5.1M | ||
| Q2 24 | $-3.3M | $-7.3M | ||
| Q1 24 | $-58.0K | $-5.7M |
| Q4 25 | $-23.6M | — | ||
| Q3 25 | $-5.7M | — | ||
| Q2 25 | $-6.0M | — | ||
| Q1 25 | $-5.1M | — | ||
| Q4 24 | $-13.5M | — | ||
| Q3 24 | $-4.3M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -867.3% | — | ||
| Q3 25 | -218.7% | — | ||
| Q2 25 | -200.5% | — | ||
| Q1 25 | -181.2% | — | ||
| Q4 24 | -511.9% | — | ||
| Q3 24 | -184.4% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | 275.4% | — | ||
| Q3 25 | 86.5% | — | ||
| Q2 25 | 6.6% | — | ||
| Q1 25 | 36.4% | — | ||
| Q4 24 | 338.7% | — | ||
| Q3 24 | 196.7% | — | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | 0.0% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -3.51× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.79× | — | ||
| Q2 24 | -1.55× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
